Acute SARS-CoV-2 infection of WAT adipocytes and macrophages [49–52] suggests an additional mechanism through which obesity could influence COVID-19 severity; i.e., an increased number of cells susceptible to infection and subsequent pathologies such as dyslipidemia and increased inflammatory cytokine release and worsening insulin sensitivity. This evidence concerns the gene INS and obesity disorder.